Haaartland

Login
CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines

inBrighter #Type1diabetes

CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines

Source: markets.businessinsider.com

Bo

Bo

Your sidekick
Sweden

Bo
Your sidekick

  • 0

SAN DIEGO, Dec. 15, 2017 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, today announced that the California Institute for Regenerative Medicine (CIRM) approved a grant of $1.4 million to support the initial development of immune-evasive pluripotent stem cell lines.  The focus of the project will be to genetically engineer

View original